Acyclovir, a widely used drug for treating genital herpes, is being tested to evaluate whether suppressing the sexually transmitted disease can reduce HIV transmission.
The Partners in Prevention study is being conducted on over
The University of Washington is undertaking the study with funding from the Bill and Melinda Gates Foundation.
In Africa, research has found that 50% of HIV-negative and 80% of HIV positive persons have genital herpes, suggesting a strong link between the two infections.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.